ABOS
Price
$1.32
Change
-$0.07 (-5.04%)
Updated
Sep 12 closing price
Capitalization
79.96M
65 days until earnings call
CELC
Price
$54.91
Change
-$2.52 (-4.39%)
Updated
Sep 12 closing price
Capitalization
2.33B
65 days until earnings call
Interact to see
Advertisement

ABOS vs CELC

Header iconABOS vs CELC Comparison
Open Charts ABOS vs CELCBanner chart's image
Acumen Pharmaceuticals
Price$1.32
Change-$0.07 (-5.04%)
Volume$163.99K
Capitalization79.96M
Celcuity
Price$54.91
Change-$2.52 (-4.39%)
Volume$1.01M
Capitalization2.33B
ABOS vs CELC Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. CELC commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and CELC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (ABOS: $1.32 vs. CELC: $54.91)
Brand notoriety: ABOS and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 44% vs. CELC: 63%
Market capitalization -- ABOS: $79.96M vs. CELC: $2.33B
ABOS [@Biotechnology] is valued at $79.96M. CELC’s [@Biotechnology] market capitalization is $2.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileCELC’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CELC’s FA Score: 1 green, 4 red.
According to our system of comparison, CELC is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while CELC’s TA Score has 3 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 6 bearish.
  • CELC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ABOS and CELC are a bad buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а -8.33% price change this week, while CELC (@Biotechnology) price change was -1.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

CELC is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($2.33B) has a higher market cap than ABOS($80M). CELC YTD gains are higher at: 319.481 vs. ABOS (-23.256). ABOS (-132.35M) and CELC (-135.56M) have comparable annual earnings (EBITDA) . CELC has more cash in the bank: 168M vs. ABOS (143M). ABOS has less debt than CELC: ABOS (30.1M) vs CELC (99.4M). ABOS (0) and CELC (0) have equivalent revenues.
ABOSCELCABOS / CELC
Capitalization80M2.33B3%
EBITDA-132.35M-135.56M98%
Gain YTD-23.256319.481-7%
P/E RatioN/AN/A-
Revenue00-
Total Cash143M168M85%
Total Debt30.1M99.4M30%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
23
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSCELC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 27 days ago
78%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDGCX15.24N/A
N/A
Crawford Large Cap Dividend C
QKBGX23.79N/A
N/A
Federated Hermes MDT Balanced R6
MMUGX24.26N/A
N/A
MFS Utilities R1
HNDRX83.23N/A
N/A
Horizon Defined Risk Investor
ACIHX68.91N/A
N/A
American Century Growth G